Albert Dyrness Net Worth & Insider Trades

Albert Dyrness - Director, Sonnet Biotherapeutics Holdings, Inc

As of April 8, 2022

What is Albert Dyrness's Net Worth?

The current estimated net worth of Sonnet Biotherapeutics Holdings, Inc's Director, Albert Dyrness, is estimated to be about $613.68 . Albert Dyrness owns about 4,966 units of Sonnet Biotherapeutics Holdings, Inc common stock. In the last 2 years at Sonnet Biotherapeutics Holdings, Inc, Albert Dyrness has sold an estimated value of $0 worth.

What is Albert Dyrness's Past Insider Trading?

Albert Dyrness's largest purchase order was 2,409 units , worth over $9.66K on June 12, 2020. In total, Albert Dyrness has made about 4 transactions over 2 years of their time at Sonnet Biotherapeutics Holdings, Inc. Albert Dyrness usually trades in April, with the busiest year in 2020.

Albert Dyrness

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Albert Dyrness's' Mailing Address?

  • Mailing address is C/o Sonnet Biotherapeutics Holdings, Inc 100 Overlook Center Princeton NJ 08540 NJ

Sonnet Biotherapeutics Holdings, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Compensation
Total
Pankaj Mohan, Ph.D. 2020 $490,000 $243,954 $1,161,114 - - $1,895,068
Pankaj Mohan, Ph.D. 2019 $367,500 $180,616 - - - $548,116
John Cini, Ph.D. 2020 $290,000 $98,740 $283,917 - - $672,657
John Cini, Ph.D. 2019 $102,000 $38,769 - - - $140,769
Jay Cross 2020 $307,500 $113,555 $283,917 - - $704,972
Jay Cross 2019 $104,167 $21,405 - - - $125,572
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1106838/000149315221012861/formdef14a.htm

What are Sonnet Biotherapeutics Holdings, Inc's Past Insider Trades?

Sonnet Biotherapeutics Holdings, Inc's most recent insider trade came on June 9, 2021 by Richard Kenney who bought 15,000 units worth $23.1K . In the last year, insiders at Sonnet Biotherapeutics Holdings, Inc have sold an estimated value of $44.52K and bought an estimated value of $107.66K worth of shares. Insider trading is most common in April, with the busiest year in 2020. The most active traders at the company are Pankaj Mohan, Chairman,  Albert Dyrness, Director,  and Donald Griffith, Director .

Sonnet BioTherapeutics Holdings, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1